# Oocyte cryopreservation for fertility preservation in transgender and gender diverse individuals: a SWOT analysis

## TL;DR

This paper explores the use of oocyte cryopreservation for preserving fertility in transgender and gender-diverse individuals through a SWOT analysis.

## Contribution

The paper introduces a SWOT analysis framework to guide healthcare providers in fertility preservation for gender-diverse patients.

## Key findings

- Oocyte cryopreservation is a viable option for fertility preservation in gender-diverse individuals.
- Healthcare providers need better guidance to address the unique needs of these patients.
- A SWOT analysis helps in making informed, patient-centered fertility decisions.

## Abstract

Gender affirming hormone therapy may be used to relieve dysphoria among transgender or gender-diverse individuals. However, the long-term effects of these treatments on reproductive health remain uncertain. Before initiating hormone therapy, it is essential that patients are fully informed about the potential impact on their reproductive capabilities. Fertility preservation options, such as oocyte cryopreservation, should be offered to gender diverse individuals who were assigned female at birth. To assist healthcare providers in navigating the complexities of fertility preservation for these patients, we conducted a SWOT (Strengths, Weaknesses, Opportunities, and Threats) analysis focused of oocyte cryopreservation. This analysis aims to ensure that decisions are both clinically sound and aligned with the patient's reproductive goals.